Clinical Lung Cancer

artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of first-line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas

Pub Date : 2024-02-01 DOI: 10.1016/j.cllc.2024.02.002 Yusuke Okuma, S. Nomura, Jun Sakakibara-Konishi, Y. Tsukita, Shuji Murakami, Y. Hosomi, Yuichi Tambo, Yoshihito Kogure, H. Yoshioka, M. Tamiya, Kiichiro Ninomiya, Eiji Iwama

A retrospective real-world study of prognostic factors associated with EGFR mutated lung cancer with leptomeningeal metastasis

Pub Date : 2024-02-01 DOI: 10.1016/j.cllc.2024.02.001 Yingxi Wu, Yuhua Zhao, Yufeng Wu, Haiyang Chen, Shuxiang Ma, Qiming Wang

Perioperative immunotherapy for non-small cell lung cancer: practical application of emerging data and new challenges

Pub Date : 2024-02-01 DOI: 10.1016/j.cllc.2024.02.004 A. D'Aiello, Brendon M Stiles, Nitin Ohri, Benjamin Levy, Perry Cohen, B. Halmos